BiotechTube

Clopidogrel + Clopidogrel placebo + Aspirin

ApprovedCompleted
0 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Stroke

Conditions

Stroke

Trial Timeline

Dec 1, 2008 → May 1, 2012

NCT ID
NCT00814268

About Clopidogrel + Clopidogrel placebo + Aspirin

Clopidogrel + Clopidogrel placebo + Aspirin is a approved stage product being developed by Bristol Myers Squibb for Stroke. The current trial status is completed. This product is registered under clinical trial identifier NCT00814268. Target conditions include Stroke.

What happened to similar drugs?

12 of 20 similar drugs in Stroke were approved

Approved (12) Terminated (6) Active (5)
✅StatinShionogiApproved
✅AlteplaseKyowa KirinApproved
✅RepathaAmgenApproved
✅DonepezilPfizerApproved
✅Oral Anticoagulant + Antiplatelet DrugPfizerApproved
✅Eicosapentaenoic acid ethyl ester(EPADEL Capsule 300 TM)Mochida PharmaceuticalApproved
✅Enoxaparin sodiumSanofiApproved

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00814268ApprovedCompleted

Competing Products

20 competing products in Stroke

See all competitors
ProductCompanyStageHype Score
SPT-07A injectionSinopharmPhase 3
36
Osmotic drugsSinopharmPre-clinical
33
Aspirin, ClopidogrelYuhanPre-clinical
26
DS-1040b + PlaceboDaiichi SankyoPhase 1/2
32
SUN13837 + placeboDaiichi SankyoPhase 2
27
DS-1040b + AspirinDaiichi SankyoPhase 1
29
piclozotan low dose + placebo + piclozotan high doseDaiichi SankyoPhase 2
27
DS1040b + PlaceboDaiichi SankyoPre-clinical
26
Pharmacological intensification based on olmesartanDaiichi SankyoPhase 2
35
warfarin tablets + Edoxaban tablets (high dose regimen-60mg) + Edoxaban tablets (low dose regimen-30mg) + placebo warfarin + placebo edoxabanDaiichi SankyoPhase 3
40
YM872 (zonampanel), t-PA (alteplase)Astellas PharmaPhase 2
35
ASP2246Astellas PharmaPhase 1/2
39
Neu2000KWL + Neu2000KWL + Neu2000KWL + PlacebosSun PharmaceuticalPhase 2
35
XY03-EA + XY03-EA PlaceboSun PharmaceuticalPhase 2
31
Redasemtide + PlaceboShionogiPhase 2
39
StatinShionogiApproved
43
AlteplaseKyowa KirinApproved
43
ONO-2506 + ONO-2506 + ONO-2506Ono PharmaceuticalPhase 2/3
38
AbciximabEli LillyPhase 3
32
AbciximabEli LillyPhase 3
32